During the past decade, Herz- und Gefäßzentrum Oberallgäu-Kempten conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herz- und Gefäßzentrum Oberallgäu-Kempten" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Herz- und Gefäßzentrum Oberallgäu-Kempten" are "Coronary Artery Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Herz- und Gefäßzentrum Oberallgäu-Kempten" in a lesser frequency.

Most popular intervention types in "Herz- und Gefäßzentrum Oberallgäu-Kempten" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold" (1 trials) and "Magmaris" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herz- und Gefäßzentrum Oberallgäu-Kempten" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Herz- und Gefäßzentrum Oberallgäu-Kempten". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Herz- und Gefäßzentrum Oberallgäu-Kempten, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herz- und Gefäßzentrum Oberallgäu-Kempten, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".